Abstract
Controversy exists about the value of antibiotic therapy following incision and drainage of cutaneous abscess. We undertook a randomized double-blind study to clarify the controversy. Adult patients with cutaneous abscesses who received outpatient surgical therapy were entered into the study. Following incision and drainage, patients received cephradine or placebo for seven days using a randomized code in a double-blind fashion. At the end of seven days, patients were reevaluated. Twenty-seven patients were treated with cephradine, and 23 with placebo. Ninety-six percent of the patients in each group were improved clinically after seven days. We conclude that cephradine did not alter the outcome of cutaneous abscesses at one week after incision and drainage. The implications are twofold: patients are not exposed to the potential side effects and allergic reactions of antibiotics, and the cost of health care can be reduced by not prescribing antibiotics in these patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
